Related Experiment Videos
Venous ulcer care: which dressings are cost effective?
1Department of Surgery, University of Washington, Seattle, Washington, USA meissner@u.washington.edu.
Insights
Venous leg ulcers affect many and are costly. Current evidence offers little guidance on the best primary dressings, suggesting a patient-centered approach is best.
Area of Science:
- Wound healing research
- Vascular medicine
- Healthcare economics
Background:
- Venous leg ulcers affect up to 1% of Western populations, leading to significant healthcare costs.
- These chronic wounds exhibit impaired healing due to inflammation and can take months to close.
- The average monthly cost for managing an open venous leg ulcer is estimated at $4095.
Approach:
- Review of current wound care practices for venous ulcers.
- Analysis of available primary dressing options, including specialized products.
- Evaluation of clinical data and cost-effectiveness of different dressings.
Key Points:
- Standard care involves compression and a moist wound environment.
- Numerous specialized dressings exist, but robust clinical data supporting superior outcomes is limited.
- Data on the cost-effectiveness of advanced dressings is scarce, conflicting, and potentially biased.
Conclusions:
- There is a lack of strong evidence to guide the selection of primary dressings for venous ulcers.
- A patient-centered approach, considering individual patient and ulcer characteristics alongside costs, is recommended.
- Further research is needed to establish evidence-based guidelines for dressing selection and cost-effectiveness.
Abstract:
Healed or open venous ulcers may be present in up to 1% of Western populations and consume a large amount of healthcare resources. These ulcers are characterized by a chronic inflammatory environment with impaired healing and often require months for closure. The average monthly cost of care for an open ulcer has been estimated to be $4095. The fundamental tenets of ulcer care include adequate compression and maintaining a moist wound environment with an appropriate primary dressing. A number of specialized products including semi-occlusive/occlusive, antimicrobial, and advanced wound matrix dressings are now available. However, there is little data from appropriate clinical studies to suggest significantly improved outcomes with any of these dressings. Data regarding their cost-effectiveness is also limited, often conflicting, and subject to bias. At present, there is little solid evidence to guide the choice of primary dressings and a patient-centered approach focusing on characteristics of both the patient and their ulcer, while paying attention to costs, may be most appropriate.